4//SEC Filing
Narayan Prabhu 4
Accession 0001437749-24-029387
CIK 0001742927other
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 5:01 PM ET
Size
6.2 KB
Accession
0001437749-24-029387
Insider Transaction Report
Form 4
Narayan Prabhu
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2024-09-15+96,519→ 96,519 totalExercise: $1.20Exp: 2034-09-14→ Common Stock, par value $0.0001 per shae (96,519 underlying)
Footnotes (1)
- [F1]Represents an option award (the "Option") granted to Mr. Narayan Prabhu, the Issuer's Chief Financial Officer (the "Reporting Person"), by the Issuer's compensation committee (the "Compensation Committee") on September 15, 2024 (the "Grant Date") in accordance with the terms of the Issuer's 2020 Equity Incentive Plan (the "2020 Plan"). On the Grant Date, the Compensation Committee determined the amount of incentive bonus earned by Mr. Prabhu for 2023 and determined that the Issuer would pay the incentive bonus in the form of fully vested options in lieu of cash payment. The Option, which is fully vested on the Grant Date, represents payment of Mr. Prabhu's incentive bonus earned for 2023. The exercise price of the Option is based on the closing price of the Issuer's common stock on September 13, 2024, in accordance with the terms of the 2020 Plan.
Documents
Issuer
REVIVA PHARMACEUTICALS HOLDINGS, INC.
CIK 0001742927
Entity typeother
Related Parties
1- filerCIK 0001829831
Filing Metadata
- Form type
- 4
- Filed
- Sep 16, 8:00 PM ET
- Accepted
- Sep 17, 5:01 PM ET
- Size
- 6.2 KB